US Stock MarketDetailed Quotes

Kestra Medical Technologies (KMTS)

Watchlist
  • 24.385
  • -0.325-1.32%
Trading Jan 23 15:30 ET
1.42BMarket Cap-9.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kestra Medical Technologies (KMTS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Oct 31, 2025
(Q1)Jul 31, 2025
(FY)Apr 30, 2025
(Q4)Apr 30, 2025
(Q3)Jan 31, 2025
(Q2)Oct 31, 2024
(Q1)Jul 31, 2024
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
(Q3)Jan 31, 2024
Total revenue
53.40%22.57M
51.55%19.37M
115.05%59.82M
71.40%17.23M
82.31%15.09M
14.71M
12.78M
264.53%27.81M
10.05M
8.28M
Operating revenue
53.40%22.57M
51.55%19.37M
115.05%59.82M
71.40%17.23M
82.31%15.09M
--14.71M
--12.78M
264.53%27.81M
--10.05M
--8.28M
Cost of revenue
25.46%11.14M
22.58%10.52M
29.70%35.61M
10.89%9.6M
15.49%8.54M
8.88M
8.58M
50.17%27.45M
8.66M
7.4M
Gross profit
95.95%11.42M
110.74%8.85M
6,587.85%24.21M
446.39%7.63M
643.98%6.55M
5.83M
4.2M
103.40%362K
1.4M
880K
Operating expense
72.97%43.18M
66.71%37.73M
52.87%130.59M
156.81%55.85M
30.36%27.15M
24.96M
22.63M
22.44%85.43M
21.75M
20.83M
Selling and administrative expenses
78.52%38.3M
75.42%33.73M
64.35%114.94M
181.50%50.46M
39.23%23.8M
--21.46M
--19.23M
29.48%69.94M
--17.93M
--17.09M
Research and development costs
39.01%4.88M
17.54%4M
1.05%15.65M
40.96%5.39M
-10.23%3.35M
--3.51M
--3.4M
-1.69%15.49M
--3.82M
--3.74M
Operating profit
-65.96%-31.76M
-56.68%-28.88M
-25.06%-106.38M
-136.93%-48.21M
-3.28%-20.6M
-19.13M
-18.43M
-5.77%-85.06M
-20.35M
-19.95M
Net non-operating interest income expense
92.70%-105K
113.88%255K
27.21%-4.54M
94.63%-104K
30.04%-1.16M
-1.44M
-1.84M
-10.68%-6.23M
-1.94M
-1.65M
Non-operating interest income
104.56%1.8M
5,756.76%2.17M
--3.2M
--1.66M
--628K
--878K
--37K
--0
--0
--0
Non-operating interest expense
-17.95%1.9M
2.03%1.91M
24.14%7.73M
-9.04%1.76M
8.00%1.78M
--2.32M
--1.87M
10.68%6.23M
--1.94M
--1.65M
Other net income (expense)
-2,127.50%-891K
5,995.83%2.83M
1.32%-2.77M
-9,874.07%-2.69M
287.50%15K
-40K
-48K
-253.42%-2.8M
-27K
-8K
Gain on sale of security
----
----
---2.65M
----
----
----
----
----
----
----
Other non- operating income (expenses)
-2,127.50%-891K
5,995.83%2.83M
95.79%-118K
-66.67%-45K
287.50%15K
---40K
---48K
-253.42%-2.8M
---27K
---8K
Income before tax
-58.89%-32.75M
-26.96%-25.79M
-20.81%-113.68M
-128.63%-51.01M
-0.63%-21.74M
-20.61M
-20.32M
-11.72%-94.1M
-22.31M
-21.61M
Income tax
325.00%34K
371.43%33K
462.50%135K
477.78%102K
28.57%18K
8K
7K
60.00%24K
-27K
14K
Net income
-58.99%-32.79M
-27.08%-25.83M
-20.92%-113.81M
-129.36%-51.11M
-0.65%-21.76M
-20.62M
-20.32M
-11.73%-94.12M
-22.28M
-21.62M
Net income continuous Operations
-58.99%-32.79M
-27.08%-25.83M
-20.92%-113.81M
-129.36%-51.11M
-0.65%-21.76M
---20.62M
---20.32M
-11.73%-94.12M
---22.28M
---21.62M
Minority interest income
0
0
-250K
-253K
-439K
0
Net income attributable to the parent company
-60.96%-32.79M
-29.88%-25.83M
-20.92%-113.81M
-133.59%-52.05M
0.51%-21.51M
-20.37M
-19.88M
-11.73%-94.12M
-22.28M
-21.62M
Preferred stock dividends
83.32%12.32M
65.05%3.29M
83.44%3.32M
3.32M
2.38M
168.95%6.72M
1.99M
1.81M
Other preferred stock dividends
Net income attributable to common stockholders
-38.39%-32.79M
-15.98%-25.83M
-25.08%-126.14M
-127.96%-55.34M
-5.98%-24.83M
-23.69M
-22.27M
-16.26%-100.84M
-24.28M
-23.43M
Basic earnings per share
46.22%-0.64
-11.23%-0.5
-1.16%-5.13
-81.01%-2.21
57.45%-0.5013
-1.19
-0.4495
-16.26%-5.0711
-1.2209
-1.1783
Diluted earnings per share
46.22%-0.64
-11.23%-0.5
-1.16%-5.13
-81.01%-2.21
57.45%-0.5013
-1.19
-0.4495
-16.26%-5.0711
-1.2209
-1.1783
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Oct 31, 2025(Q1)Jul 31, 2025(FY)Apr 30, 2025(Q4)Apr 30, 2025(Q3)Jan 31, 2025(Q2)Oct 31, 2024(Q1)Jul 31, 2024(FY)Apr 30, 2024(Q4)Apr 30, 2024(Q3)Jan 31, 2024
Total revenue 53.40%22.57M51.55%19.37M115.05%59.82M71.40%17.23M82.31%15.09M14.71M12.78M264.53%27.81M10.05M8.28M
Operating revenue 53.40%22.57M51.55%19.37M115.05%59.82M71.40%17.23M82.31%15.09M--14.71M--12.78M264.53%27.81M--10.05M--8.28M
Cost of revenue 25.46%11.14M22.58%10.52M29.70%35.61M10.89%9.6M15.49%8.54M8.88M8.58M50.17%27.45M8.66M7.4M
Gross profit 95.95%11.42M110.74%8.85M6,587.85%24.21M446.39%7.63M643.98%6.55M5.83M4.2M103.40%362K1.4M880K
Operating expense 72.97%43.18M66.71%37.73M52.87%130.59M156.81%55.85M30.36%27.15M24.96M22.63M22.44%85.43M21.75M20.83M
Selling and administrative expenses 78.52%38.3M75.42%33.73M64.35%114.94M181.50%50.46M39.23%23.8M--21.46M--19.23M29.48%69.94M--17.93M--17.09M
Research and development costs 39.01%4.88M17.54%4M1.05%15.65M40.96%5.39M-10.23%3.35M--3.51M--3.4M-1.69%15.49M--3.82M--3.74M
Operating profit -65.96%-31.76M-56.68%-28.88M-25.06%-106.38M-136.93%-48.21M-3.28%-20.6M-19.13M-18.43M-5.77%-85.06M-20.35M-19.95M
Net non-operating interest income expense 92.70%-105K113.88%255K27.21%-4.54M94.63%-104K30.04%-1.16M-1.44M-1.84M-10.68%-6.23M-1.94M-1.65M
Non-operating interest income 104.56%1.8M5,756.76%2.17M--3.2M--1.66M--628K--878K--37K--0--0--0
Non-operating interest expense -17.95%1.9M2.03%1.91M24.14%7.73M-9.04%1.76M8.00%1.78M--2.32M--1.87M10.68%6.23M--1.94M--1.65M
Other net income (expense) -2,127.50%-891K5,995.83%2.83M1.32%-2.77M-9,874.07%-2.69M287.50%15K-40K-48K-253.42%-2.8M-27K-8K
Gain on sale of security -----------2.65M----------------------------
Other non- operating income (expenses) -2,127.50%-891K5,995.83%2.83M95.79%-118K-66.67%-45K287.50%15K---40K---48K-253.42%-2.8M---27K---8K
Income before tax -58.89%-32.75M-26.96%-25.79M-20.81%-113.68M-128.63%-51.01M-0.63%-21.74M-20.61M-20.32M-11.72%-94.1M-22.31M-21.61M
Income tax 325.00%34K371.43%33K462.50%135K477.78%102K28.57%18K8K7K60.00%24K-27K14K
Net income -58.99%-32.79M-27.08%-25.83M-20.92%-113.81M-129.36%-51.11M-0.65%-21.76M-20.62M-20.32M-11.73%-94.12M-22.28M-21.62M
Net income continuous Operations -58.99%-32.79M-27.08%-25.83M-20.92%-113.81M-129.36%-51.11M-0.65%-21.76M---20.62M---20.32M-11.73%-94.12M---22.28M---21.62M
Minority interest income 00-250K-253K-439K0
Net income attributable to the parent company -60.96%-32.79M-29.88%-25.83M-20.92%-113.81M-133.59%-52.05M0.51%-21.51M-20.37M-19.88M-11.73%-94.12M-22.28M-21.62M
Preferred stock dividends 83.32%12.32M65.05%3.29M83.44%3.32M3.32M2.38M168.95%6.72M1.99M1.81M
Other preferred stock dividends
Net income attributable to common stockholders -38.39%-32.79M-15.98%-25.83M-25.08%-126.14M-127.96%-55.34M-5.98%-24.83M-23.69M-22.27M-16.26%-100.84M-24.28M-23.43M
Basic earnings per share 46.22%-0.64-11.23%-0.5-1.16%-5.13-81.01%-2.2157.45%-0.5013-1.19-0.4495-16.26%-5.0711-1.2209-1.1783
Diluted earnings per share 46.22%-0.64-11.23%-0.5-1.16%-5.13-81.01%-2.2157.45%-0.5013-1.19-0.4495-16.26%-5.0711-1.2209-1.1783
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.65%
Sample Name
Sample Code
 +2.54%
Sample Name
Sample Code
 +2.48%
4
Amazon
AMZN
+2.14%
5
Clean Energy Fuels
CLNE
+1.75%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.40%
Sample Name
Sample Code
 +8.03%
Sample Name
Sample Code
 +4.45%
4
KE Holdings
BEKE
+4.19%
5
New Oriental
EDU
+3.30%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -